News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
605,158 Results
Type
Article (43444)
Company Profile (319)
Press Release (561394)
Multimedia
Podcasts (81)
Webinars (13)
Section
Business (167858)
Career Advice (2470)
Deals (30381)
Drug Delivery (109)
Drug Development (78915)
Employer Resources (148)
FDA (14514)
Job Trends (13016)
News (296662)
Policy (28719)
Tag
Academia (2687)
Academic (1)
Accelerated approval (10)
Adcomms (29)
Allergies (97)
Alliances (43157)
ALS (116)
Alzheimer's disease (1516)
Antibody-drug conjugate (ADC) (175)
Approvals (14495)
Artificial intelligence (315)
Autoimmune disease (34)
Automation (18)
Bankruptcy (327)
Best Places to Work (10675)
BIOSECURE Act (16)
Biosimilars (111)
Biotechnology (258)
Bladder cancer (97)
Brain cancer (37)
Breast cancer (371)
Cancer (2925)
Cardiovascular disease (234)
Career advice (2080)
Career pathing (32)
CAR-T (196)
CDC (30)
Cell therapy (525)
Cervical cancer (21)
Clinical research (64804)
Collaboration (1019)
Company closure (3)
Compensation (499)
Complete response letters (29)
COVID-19 (2607)
CRISPR (66)
C-suite (352)
Cystic fibrosis (115)
Data (3014)
Decentralized trials (2)
Denatured (16)
Depression (73)
Diabetes (345)
Diagnostics (5888)
Digital health (19)
Diversity (5)
Diversity, equity & inclusion (41)
Drug discovery (143)
Drug pricing (126)
Drug shortages (26)
Duchenne muscular dystrophy (131)
Earnings (62591)
Editorial (44)
Employer branding (20)
Employer resources (137)
Events (91467)
Executive appointments (879)
FDA (16114)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (917)
Gene editing (141)
Generative AI (24)
Gene therapy (412)
GLP-1 (824)
Government (4352)
Grass and pollen (5)
Guidances (177)
Healthcare (17276)
HIV (41)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (174)
Immuno-oncology (9)
Indications (39)
Infectious disease (2785)
Inflammatory bowel disease (160)
Inflation Reduction Act (13)
Influenza (65)
Intellectual property (122)
Interviews (529)
IPO (14331)
IRA (50)
Job creations (2751)
Job search strategy (1698)
Kidney cancer (15)
Labor market (33)
Layoffs (488)
Leadership (25)
Legal (6104)
Liver cancer (80)
Longevity (10)
Lung cancer (419)
Lymphoma (205)
Machine learning (11)
Management (52)
Manufacturing (365)
MASH (98)
Medical device (11215)
Medtech (11219)
Mergers & acquisitions (16738)
Metabolic disorders (876)
Multiple sclerosis (97)
NASH (23)
Neurodegenerative disease (128)
Neuropsychiatric disorders (41)
Neuroscience (2233)
NextGen: Class of 2025 (5958)
Non-profit (4140)
Now hiring (42)
Obesity (440)
Opinion (253)
Ovarian cancer (101)
Pain (110)
Pancreatic cancer (119)
Parkinson's disease (193)
Partnered (21)
Patents (298)
Patient recruitment (164)
Peanut (51)
People (54502)
Pharmaceutical (55)
Pharmacy benefit managers (17)
Phase I (20351)
Phase II (28618)
Phase III (21309)
Pipeline (1635)
Policy (203)
Postmarket research (2395)
Preclinical (8641)
Press Release (60)
Prostate cancer (142)
Psychedelics (45)
Radiopharmaceuticals (266)
Rare diseases (502)
Real estate (4512)
Recruiting (61)
Regulatory (20767)
Reports (29)
Research institute (2284)
Resumes & cover letters (362)
Rett syndrome (10)
RNA editing (10)
RSV (46)
Schizophrenia (94)
Series A (158)
Series B (110)
Service/supplier (3)
Sickle cell disease (64)
Special edition (16)
Spinal muscular atrophy (154)
Sponsored (31)
Startups (3193)
State (2)
Stomach cancer (15)
Supply chain (67)
Tariffs (50)
The Weekly (64)
Vaccines (763)
Venture capital (54)
Weight loss (281)
Women's health (37)
Worklife (17)
Date
Today (90)
Last 7 days (343)
Last 30 days (1754)
Last 365 days (29856)
2025 (16138)
2024 (33555)
2023 (37504)
2022 (48407)
2021 (52035)
2020 (50006)
2019 (42511)
2018 (32046)
2017 (29623)
2016 (28219)
2015 (32950)
2014 (25391)
2013 (20578)
2012 (21802)
2011 (22728)
2010 (20440)
Location
Africa (749)
Alabama (64)
Alaska (4)
Arizona (180)
Arkansas (12)
Asia (36852)
Australia (7290)
California (6946)
Canada (2269)
China (665)
Colorado (301)
Connecticut (281)
Delaware (191)
Europe (82670)
Florida (1047)
Georgia (226)
Hawaii (1)
Idaho (57)
Illinois (587)
India (26)
Indiana (317)
Iowa (14)
Japan (227)
Kansas (99)
Kentucky (26)
Louisiana (14)
Maine (55)
Maryland (972)
Massachusetts (5149)
Michigan (228)
Minnesota (398)
Mississippi (3)
Missouri (87)
Montana (24)
Nebraska (22)
Nevada (74)
New Hampshire (68)
New Jersey (1993)
New Mexico (25)
New York (1951)
North Carolina (1030)
North Dakota (7)
Northern California (3009)
Ohio (206)
Oklahoma (12)
Oregon (33)
Pennsylvania (1447)
Puerto Rico (17)
Rhode Island (33)
South America (1023)
South Carolina (31)
South Dakota (1)
Southern California (2660)
Tennessee (111)
Texas (1043)
United States (25621)
Utah (207)
Virginia (170)
Washington D.C. (65)
Washington State (597)
West Virginia (4)
Wisconsin (62)
605,158 Results for "cascadian therapeutics formally known as oncothyreon".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
HHS Begins Formally Laying Off Employees
Thousands of employees across HHS were terminated Monday evening after the U.S. Supreme Court ruled last week that the Trump administration could move forward with its sweeping reorganization of the agency.
July 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia
July 8, 2025
·
6 min read
Press Releases
BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent
May 23, 2025
·
3 min read
Press Releases
Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting
May 1, 2025
·
6 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Vaccines
As New CDC Vaccine Advisors Gear Up for First Meeting, Experts Ask, ‘Where’s Cassidy?’
Scientists and analysts express concern that the newly appointed ACIP members—which include known anti-vaxxers—could relitigate recommendations that have already been made. Many are imploring Sen. Bill Cassidy to step up.
June 12, 2025
·
4 min read
·
Heather McKenzie
Duchenne muscular dystrophy
UPDATE: Second Patient Dies After Receiving Sarepta’s DMD Gene Therapy Elevidys
Sarepta’s shares crashed 41% in premarket trading Monday morning to $21.01 after the biotech reported a second death from acute liver failure, a known side effect of adeno-associated virus-based gene therapies.
June 16, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Know Labs Technology Licensing (KTL) Announces Formalized Client Engagement
February 6, 2025
·
7 min read
Press Releases
CB Scientific Inc. (CBSC) Formally Launches Next Generation MyCardia AT Cardiac Monitor
February 25, 2025
·
4 min read
1 of 60,516
Next
